Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making

被引:8
|
作者
Sola-Morales, Oriol [1 ]
Siguroardottir, Katla [1 ]
Akehurst, Ron [2 ]
Murphy, Linda A. [2 ]
Mestre-Ferrandiz, Jorge
Cunningham, David
de Pouvourville, Gerard [3 ]
机构
[1] Fdn HiTT, Barcelona, Spain
[2] Lumanity Inc, Sheffield, England
[3] ESSEC Business Sch, Cergy Pontoise, France
关键词
data governance; real-world data; real-world evidence; BIG DATA; TASK-FORCE; HEALTH;
D O I
10.1016/j.jval.2023.02.012
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Real-world data (RWD) and real-world evidence (RWE) can provide extensive information on healthcare for use in health technology assessment and decision making. Nevertheless, there is a lack of consensus surrounding the appropriate data governance (DG) practices for RWD/RWE. Data sharing is also a large concern, especially considering evolving data protection regulations. Our objective is to propose recommendations for international standards of evaluating the acceptability of RWD governance practices. Methods: After reviewing the literature, we created a checklist targeting DG practices for RWD/RWE. We then carried out a 3-round Delphi panel, including European policy makers, health technology assessment experts, and hospital managers. The consensus for each statement was measured and the checklist adjusted accordingly. Results: The literature review identified the main topics regarding RWD/RWE DG practices: data privacy and security, data management and linkage, data access management, and the generation and use of RWE. Members of the Delphi panel (21 experts/25 invited) were presented a total of 24 statements related to each of the topics. Experts demonstrated a progressive level of consensus and importance ratings in all topics and to most statements. We suggest a refined checklist in which the statements rated less important or with less consensus have been removed. Conclusions: This study suggests how the DG of RWD/RWE could be qualitatively evaluated. We propose checklists that could be used by all RWD/RWE users to help ensure the quality and integrity of RWD/RWE governance and complement data protection law.
引用
收藏
页码:32 / 42
页数:11
相关论文
共 50 条
  • [1] Real-world patient data: Can they support decision making and patient engagement?
    Joeris, Alexander
    Zhu, Tracy Y.
    Lambert, Simon
    Wood, Andrea
    Jayakumar, Prakash
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2023, 54 : S51 - S56
  • [2] Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas
    Demetri, George D.
    Stacchiotti, Silvia
    ONCOLOGY, 2021, 99 (SUPPL 1) : 3 - 7
  • [3] Support vector machine with fuzzy decision-making for real-world data classification
    Li, Boyang
    Hu, Jinglu
    Hirasawa, Kotaro
    Sun, Pu
    Marko, Kenneth
    2006 IEEE INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORK PROCEEDINGS, VOLS 1-10, 2006, : 587 - +
  • [4] SUITABILITY OF NORDIC REAL-WORLD DATA TO SUPPORT US REGULATORY DECISION-MAKING
    Geale, K.
    Grip, Toresson E.
    Ortsater, G.
    VALUE IN HEALTH, 2022, 25 (12) : S255 - S255
  • [5] CONTEXT MATTERS - A TAXONOMY OF REAL-WORLD DATA AND EVIDENCE TO SUPPORT HTA DECISION-MAKING
    Murphy, L. A.
    Mestre-Ferrandiz, J.
    Sola-Morales, O.
    de Pouvourville, G.
    Cunningham, D.
    Corry, S.
    Akehurst, R.
    VALUE IN HEALTH, 2020, 23 : S622 - S622
  • [6] REAL-WORLD DATA MANAGEMENT
    VANRENSSELAER, C
    COMPUTER DECISIONS, 1988, 20 (10): : 50 - 53
  • [7] Comparison of two assessments of real-world data and real-world evidence for regulatory decision-making
    Yuan, Lily
    Rahman, Motiur
    Concato, John
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
  • [8] Real-World Data Analytics Fit for Regulatory Decision-Making
    Schneeweiss, Sebastian
    Glynn, Robert J.
    AMERICAN JOURNAL OF LAW & MEDICINE, 2018, 44 (2-3) : 197 - 216
  • [9] Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
    Cave, Alison
    Kurz, Xavier
    Arlett, Peter
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 36 - 39
  • [10] Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making
    Franklin, Jessica M.
    Glynn, Robert J.
    Martin, David
    Schneeweiss, Sebastian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (04) : 867 - 877